DistantNews
Support us
From WBC Hero to Struggling Pitcher: Paul Skenes Faces Difficult Season, Lingering Effects of Tournament Eyed
๐Ÿ‡ฐ๐Ÿ‡ท South Korea /Sports

From WBC Hero to Struggling Pitcher: Paul Skenes Faces Difficult Season, Lingering Effects of Tournament Eyed

From Chosun Ilbo · () Korean

Translated from Korean, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • Paul Skenes, a key pitcher for the U.S. in the World Baseball Classic, is struggling in his professional baseball season.
  • Skenes has a 6-7 record with a 3.10 ERA in 17 starts, pitching 93 innings so far this season.
  • The article suggests his current difficulties might be a lingering effect from the WBC.

Paul Skenes, once hailed as America's baseball hero for his pivotal role in leading the U.S. to the World Baseball Classic finals, is now facing a challenging reality in the current professional season. Despite his past triumphs, Skenes is experiencing significant struggles on the mound, a stark contrast to his previous acclaimed performances.

This season, Skenes has started 17 games, accumulating 93 innings pitched. However, his record stands at a modest 6-7 with a 3.10 earned run average. These statistics indicate a performance that, while still considered by some to be within the normal range for a top-tier pitcher, falls short of the exceptional level expected after his WBC heroics.

The article raises the question of whether Skenes' current difficulties could be a residual effect of his intense involvement in the World Baseball Classic. The demanding nature of the tournament, combined with the transition back to the regular professional season, may be contributing to his performance dip. The year 2026 is shaping up to be a difficult one for Skenes, potentially remembered as his worst since his major league debut.

DistantNews Editorial

Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.